Currents in Contemporary Ethics: Informed Trust and the Financing of Biomedical Research

Kassirer J. P. , On the Take: How Medicine's Complicity with Big Business Can Endanger Your Health (Oxford: Oxford University Press, 2005); Angell M. , “Is Academic Medicine for Sale?” N. Engl. J. Med. 342 (2000):1516–8.

Friedman P. J. “The Impact of Conflict of Interest on Trust in Science,” Science and Engineering Ethics 8 (2000): 413–20; Bodenheimer T. , “An Uneasy Alliance: Clinical Investigators and the Pharmaceutical Industry,” N. Engl. J. Med. 342 (2000): 1539–44; Frankel M. S. , “Perception, Reality, and the Political Context of Conflict of Interest in University-Industry Relationships,” Academic Medicine 71 (1996): 1297–304.

Carmen I. H. , “A Death in the Laboratory: The Politics of the Gelsinger Aftermath,” Molecular Therapy 3 (2001): 425–8.

Steinbrook R. , “Financial Conflicts of Interest and the NIH,” N. Engl. J. Med. 350 (2004): 327–30.

Snyder E. Y. and Loring J. F. , “Beyond Fraud – Stem-Cell Research Continues,” N. Engl. J. Med. 354 (2006): 321–4.

Morin K. Rakatansky J. Riddick F. A. Jr. Morse L. J. O'Bannon J. M. III Goldrich M. S. Ray P. Wesiss M. Sade R. M. , and Spillman M. A. , “Managing Conflicts of Interest in the Conduct of Clinical Trials,” JAMA 287 (2002): 78–84; Montaner J. D. O'Shaughnessy M. V. , and Schechter M. T. , “Industry-Sponsored Clinical Research: A Double-Edged Sword,” Lancet 358 (2001): 1893–5; Boyd E. A. and Bero L. A. , “Assessing Faculty Financial Relationships with Industry,” JAMA 28 (2000): 2209–14; DeAngelis C. D. Fontanarosa P. B. , and Flanagin A. , Editorial, “Reporting Financial Conflicts of Interest and Relationships between Investigators and Research Sponsors,” JAMA 286 (2001): 89–91; Korn D. , “Conflicts of Interest in Biomedical Research,” JAMA 284 (2000): 2234–7; Fontanarosa P. B. Flanagin A. , and DeAngelis C. D. , Editorial, “Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies,” JAMA 294 (2005):110–111; Lo B. Wolf L. E. , and Berkeley A. , “Conflict-of-Interest Policies for Investigators in Clinical Trials,” N. Engl. J. Med. 343 (2000): 1616–20; Moses H. III and Martin J. B. , “Academic Relationships with Industry: A New Model for Biomedical Research,” JAMA 285 (2001): 933–35; U.S. Department of Health and Human Services, “Financial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection,” Federal Register 69 (2004): 26393–26937; Gelijns A. C. and Thier S. O. , “Medical Innovation and Institutional Interdependence: Rethinking University-Industry Connections,” JAMA 287 (2002): 1398–99.

McCrary S. V. Anderson C. B. Jakovljevic J. Khan T. McCullough L. B. Wray N. P. , and Brody B. A. , “A National Survey of Policies on Disclosure of Conflicts of Interest in Biomedical Research,” N. Engl. J. Med. 343 (2000): 1621–6.

Cho M. K. Shohara R. Schissel A. , and Rennie D. , “Policies on Faculty Conflicts of Interest at US Universities,” JAMA 284 (2000): 2203–8.

Cohen J. J. “Trust Us to Make a Difference: Ensuring Public Confidence in the Integrity of Clinical Research,” Academic Medicine 76 (2001): 209–214; Kelch R. P. , “Maintaining the Public Trust in Clinical Research,” N. Engl. J. Med. 346 (2002): 285–7; Johns M. M. E. Barnes M. , and Florencio P. S. , “Restoring Balance to Industry-Academia Relationships in an Era of Institutional Financial Conflicts of Interest: Promoting Research While Maintaining Trust,” JAMA 289 (2003): 741–6.

Stossel T. P. , “Regulating Academic-Industrial Research Relationships – Solving Problems of Stifling Progress,” N. Engl. J. Med. 353 (2005): 1060–65.

Yarborough M. and Sharp R. R. , “Restoring and Preserving Trust in Biomedical Research,” Academic Medicine 77 (2002): 8–14.

Werhane P. and Doering J. , “Conflicts of Interests and Conflicts of Commitment,” Professional Ethics 4 (1995): 47–81; Thompson D. F. , “Understanding Financial Conflicts of Interest,” N. Engl. J. Med. 329 (1993): 573–6; Sollitto S. Hoffman S. Mehlman M. Lederman R. J. Youngner S. J. , and Lederman M. M. , “Intrinsic Conflicts of Interest in Clinical Research: A Need for Disclosure,” Kennedy Institute of Ethics Journal 13 (2003): 83–91.

Pellegrino E. D. and Thomasma D. C. , For the Patient's Good: The Restoration of Beneficence in Health Care (New York: Oxford University Press, 1988).

Veatch R. M. , Patient as Partner: A Theory of Human-Experimentation Ethics (Bloomington: Indiana University Press, 1987).

Angell M. , The Truth About the Drug Companies: How They Deceive Us and What To Do About It (New York: Random House, 2004).

Blumenthal D. , “Relationships between Academic Institutions and Industry in the Life Sciences,” N. Engl. J. Med. 334 (1996): 368–74.

Cohen J. J. and Siegel E. K. , “Academic Medical Centers and Medical Research: The Challenges Ahead,” JAMA 294 (2005): 1367–72.

Bok D. , Universities In the Marketplace (Princeton: Princeton University Press, 2003).

Krimsky S. , Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? (Lanham: Rowman & Littlefield Publishers, Inc., 2003).

Dresser R. , When Science Offers Salvation: Patient Advocacy and Research Ethics (New York: Oxford University Press, 2001).

Finkel M. J. , “Should Informed Consent Include Information on How Research is Funded?” IRB 13 (1991): 1–3.

Caulfield T. and Griener G. , “Conflicts of Interest in Clinical Research: Addressing the Issue of Physician Remuneration,” Journal of Law, Medicine & Ethics 30 (2002): 305–8.

Beauchamp T. L. and Childress J. F. , Principles of Biomedical Ethics, 4th ed. (New York: Oxford University Press, 1994).

Faden R. R. and Beauchamp T. L. , A History and Theory of Informed Consent (New York: Oxford University Press, 1986).

La Puma J. , “Physicians' Conflicts of Interest in Postmarketing Research: What the Public should Know and Why Industry should Tell them,” in Vanderpool H. Y. , ed., The Ethics of Research Involving Human Subjects: Facing the 21st Century (Frederick, MD: University Publishing Group, 1996): 203–219.

Brody B. A. McCullough L. B. , and Sharp R. R. , “Consensus and Controversy in Clinical Research Ethics,” JAMA 294 (2005): 1411–4.

Vinicky J. K. Edwards S. S. , and Orlowski J. P. , “Conflicts of Interest, Conflicting Interests, and Interesting Conflicts,” Journal of Clinical Ethics 6 (1995): 358–66.

Sugarman J. McCrory D. C. Powell D. Krasny A. Adams B. Ball E. , and Cassell C. , “Empirical Research on Informed Consent. An Annotated Bibliography,” Hastings Center Report 29 (1999): S1–42.

Appelbaum P. S. Roth L. H. Lidz C. W. Benson P. , and Winslade W. , “False Hopes and Best Data: Consent to Research and the Therapeutic Misconception,” Hastings Center Report 17 (1987): 20–4.

Wilkinson T. M. , “Research, Informed Consent and the Limits of Disclosure,” Bioethics 15 (2001): 341–363.

Kahn J. P. and Mastroianni A. C. , “Moving from Compliance to Conscience: Why We Can and Should Improve on the Ethics of Clinical Research,” Archives of Internal Medicine 161 (2001): 925–8.